Results 41 to 50 of about 1,559,737 (159)
Glaucoma is a progressive optic neuropathy defined by retinal ganglion cells loss and characteristic visual field loss. It is a leading cause of irreversible blindness and affects over 60 million people worldwide. Its prevalence is estimated to increase to 111.8 million by 2040.
Pushpinder Kanda, Garfield Miller
openaire +1 more source
Jullia A Rosdahl, Divakar Gupta Department of Ophthalmology, Duke University, Durham, NC 27710, USACorrespondence: Jullia A RosdahlDepartment of Ophthalmology, Duke University, 2351 Erwin Road, DUMC 3802, Durham, NC 27710, USATel +1 919-684-8850Fax +1 ...
Rosdahl JA, Gupta D
doaj
Optic neuropathy and glaucoma cause permanent visual deficits via retinal ganglion cell (RGC) loss and axon degeneration, affecting millions worldwide. Current treatments slow disease progression but cannot restore lost vision due to regeneration failure in adult RGCs.
Emma Beard +4 more
wiley +1 more source
Canaloplasty versus Nonpenetrating Deep Sclerectomy: 2‐Year Results and Quality of Life Assessment
Purpose. To compare phacocanaloplasty (PC) and phaco‐non‐penetrating deep sclerectomy (PDS). Methods. 75 patients with uncontrolled glaucoma and cataract were randomized for PC (37 eyes) or PDS (38 eyes). Intraocular pressure (IOP) and number of medications (meds) were prospectively evaluated.
Anna Byszewska +3 more
wiley +1 more source
A novel suprachoroidal microinvasive glaucoma implant: in vivo biocompatibility and biointegration
Background A major challenge for any glaucoma implant is their ability to provide long-term intraocular pressure lowering efficacy. The formation of a low-permeability fibrous capsule around the device often leads to obstructed drainage channels, which ...
Ian Grierson +7 more
doaj +1 more source
Resveratrol (RES) exerts antioxidant and antiapoptotic effects on retinal ganglion cells (RGC) through various cellular and molecular mechanisms. First, RES has been found to protect RGCs from damage induced by oxidative stress and inflammation. It inhibits hypoxia‐induced RGC mortality by downregulating apoptosis and the production of ErbB2, a protein
Maryam Golmohammadi +10 more
wiley +1 more source
Purpose. To evaluate changes in flow density after the implantation of a trabecular microbypass stent (iStent) in combination with cataract surgery. Methods. A total of 48 eyes of 48 patients, who underwent either cataract surgery alone (cataract group) or cataract surgery with implantation of two iStent inject devices (iStent group), were ...
Maged Alnawaiseh +5 more
wiley +1 more source
A Health-Related Quality of Life Measure for Patients Who Undergo Minimally Invasive Glaucoma Surgery [PDF]
PURPOSE: To develop a patient-reported outcome measure to assess the impact of glaucoma and treatment, including minimally invasive glaucoma surgery (MIGS).
Spaeth, George l. +7 more
core +2 more sources
Background Various surgical techniques have been described, to be combined with cataract surgery in glaucoma patients, aiming for an additional reduction of intraocular pressure (IOP), hence minimizing the burden of anti-glaucoma medication (AGM ...
Magda A. Torky +3 more
doaj +1 more source
Update on Minimally Invasive Glaucoma Surgery (MIGS) and New Implants [PDF]
Traditional glaucoma surgery has been challenged by the advent of innovative techniques and new implants in the past few years. There is an increasing demand for safer glaucoma surgery offering patients a timely surgical solution in reducing intraocular ...
Lívia M. Brandão +3 more
core +1 more source

